PANAPHIX Trademark

Trademark Overview


On Thursday, September 15, 2022, a trademark application was filed for PANAPHIX with the United States Patent and Trademark Office. The USPTO has given the PANAPHIX trademark a serial number of 97592485. The federal status of this trademark filing is REGISTERED as of Tuesday, October 17, 2023. This trademark is owned by Komipharm International Co., Ltd.. The PANAPHIX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Chemotherapy medicines; Tumor suppressing agents; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical agents affecting metabolism; Chemical preparations for pharmaceutical purposes, namely, for the treatment of pain and inflammation associated with cancer, the treatment of cancer, the treatment of leukemia and lymphoma, the treatment of metastatic neoplastic diseases, the treatment of brain tumors, cancer stem cell-targeted and drug resistant cancer therapy, the treatment of urogenital cancer and its metastasis
panaphix

General Information


Serial Number97592485
Word MarkPANAPHIX
Filing DateThursday, September 15, 2022
Status700 - REGISTERED
Status DateTuesday, October 17, 2023
Registration Number7195224
Registration DateTuesday, October 17, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 1, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of immune system related diseases and disorders; Chemotherapy medicines; Tumor suppressing agents; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical agents affecting metabolism; Chemical preparations for pharmaceutical purposes, namely, for the treatment of pain and inflammation associated with cancer, the treatment of cancer, the treatment of leukemia and lymphoma, the treatment of metastatic neoplastic diseases, the treatment of brain tumors, cancer stem cell-targeted and drug resistant cancer therapy, the treatment of urogenital cancer and its metastasis

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 29, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKomipharm International Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressGyeonggi-do 15094
KR

Party NameKomipharm International Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGyeonggi-do 15094
KR

Party NameKomipharm International Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGyeonggi-do 15094
KR

Trademark Events


Event DateEvent Description
Tuesday, October 17, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 17, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, August 1, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 1, 2023PUBLISHED FOR OPPOSITION
Wednesday, July 12, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 27, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 27, 2023EXAMINER'S AMENDMENT ENTERED
Tuesday, June 27, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, June 27, 2023EXAMINERS AMENDMENT E-MAILED
Tuesday, June 27, 2023EXAMINERS AMENDMENT -WRITTEN
Tuesday, June 27, 2023ASSIGNED TO EXAMINER
Thursday, September 29, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 19, 2022NEW APPLICATION ENTERED